Cogent Biosciences
Edit

Cogent Biosciences

https://www.cogentbio.com/
Last activity: 29.05.2024
Active
Categories: BioTechCauseDevelopmentDrugLearnPlatform
Cogent Biosciences is rationally designing precision therapies that treat the underlying cause of disease to improve patients’ lives.
Mentions
7
Location: United States, Massachusetts, Waltham
Total raised: $150M

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
13.06.2022-$150M-

Mentions in press and media 7

DateTitleDescription
29.05.2024Business | Boulder’s Cogent Biosciences names chief commercial officer-
06.04.2021Cogent Biosciences Announces Creation of Cogent Research Team
04.12.2020Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares
30.11.2020Cogent Biosciences Announces $60.0 Million Public Offering of Shares of Common Stock
18.11.2020Cogent Biosciences Announces Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients at CTOS 2020
01.04.2020Japanese AI startup Cogent Labs nets USD 13 million to expand in AsiaCogent Labs, an AI solutions provider based in Tokyo, announced that it has raised JPY 1.4 billion (USD 13 million) in a Series C funding round, bringing its total funding to JPY 4.2 billion (USD 39 million). Aizawa-4 Limited Partnership, I...
10.05.2007Cogent Health, maker of healthcare IT systems, raises $3MCogent Health Solutions, a Vancouver-based provider of computerized systems for managing cancer care, raised $3 million in its first funding round. Yaletown Venture Partners led the deal, joined by angel investors. Cogent’s Web-based system...

Reviews 0

Sign up to leave a review

Sign up Log In